SCHEMBL2520193

SCHEMBL2520193

O=C1C=C/C(=C/c2ccc(Br)s2)S1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.45
MEN1 O00255 5/20 0.45
ALPL P05186 1/20 0.45
HSP90AA1 P07900 1/20 0.45
ALPI P09923 1/20 0.45
ALPG P10696 1/20 0.45
G6PD P11413 1/20 0.45
TNFRSF1A P19438 1/20 0.42
POLB P06746 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
MAPT P10636 5/20 0.38
ALDH1A1 P00352 3/20 0.38
HTT P42858 2/20 0.38
HPGD P15428 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
PKM P14618 1/20 0.35
NT5E P21589 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2520199 1.00 KMT2A (0.45) KMT2AMEN1ALPLHSP90AA1ALPI
SCHEMBL2522094 0.80 ALDH1A1 (0.33) KMT2AMAPTALDH1A1HPGDTDP1
SCHEMBL2522092 0.80 ALDH1A1 (0.33) KMT2AMAPTALDH1A1HPGDTDP1
SCHEMBL2519294 0.75 TUBB4A (0.39) KMT2AMAPTALDH1A1HPGDTDP1
SCHEMBL2519293 0.75 TUBB4A (0.39) KMT2AMAPTALDH1A1HPGDTDP1
SCHEMBL2520389 0.71 DPP4 (0.54) KMT2AMEN1POLBL3MBTL1MAPT
SCHEMBL2514798 0.69 KMT2A (0.51) KMT2AMEN1POLBL3MBTL1MAPT
SCHEMBL2514796 0.69 KMT2A (0.51) KMT2AMEN1POLBL3MBTL1MAPT
SCHEMBL30385287 0.67 MEN1 (0.51) KMT2AMEN1ALPLHSP90AA1ALPI
SCHEMBL2145506 0.66 PIM1 (0.44) KMT2AMEN1POLBL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110250254-A1 ANTIMICROBIAL COMPOSITIONS AND USES UNIVERSITETET I OLSO (NO) 2011-10-13 US disclosed
US-20110250254-A1 ANTIMICROBIAL COMPOSITIONS AND USES UNIVERSITETET I OLSO (NO) 2011-10-13 US disclosed
US-20110250254-A1 ANTIMICROBIAL COMPOSITIONS AND USES UNIVERSITETET I OLSO (NO) 2011-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110250254-A1 ANTIMICROBIAL COMPOSITIONS AND USES CBR3, C5, C3AR1 KMT2A 4318/4885MEN1 2009/4885ALPL 4698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.